Sinomune Pharmaceutical Co., Ltd.
π¨π³China
- Country
- π¨π³China
- Ownership
- Holding, Subsidiary
- Established
- 1999-03-11
- Employees
- -
- Market Cap
- -
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Phase 3
Completed
- Conditions
- ESRDHyperphosphatemiaEnd Stage Renal Disease
- Interventions
- Drug: Ferric citrate tablet
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sinomune Pharmaceutical Co., Ltd
- Target Recruit Count
- 239
- Registration Number
- NCT04456803
- Locations
- π¨π³
The second hospital of Dalian medical university, Dalian, China
π¨π³The second people's hospital of Huaian, Huai'an, China
π¨π³Zhuzhou Central Hospital, Zhuzhou, China
Β© Copyright 2025. All Rights Reserved by MedPath